Genmab nine-month revenue rises 22% as late-stage pipeline delivers
In short
Genmab's revenue for the first nine months increased by 22 percent. The revenue growth comes as the company's late-stage pipeline continues to deliver results.
Key points
- Genmab's revenue for the first nine months increased by 22 percent.: Genmab's revenue for the first nine months increased by 22 percent.
- The revenue growth comes as the company's late-stage pipeline continues to deliver result…: The revenue growth comes as the company's late-stage pipeline continues to deliver results.